期刊
LIFE-BASEL
卷 13, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/life13112213
关键词
adiponectin; AdipoRs; diabetes; pancreatic islets; single-cell RNAseq
Diabetes is a global health challenge, and adiponectin, as a hormone, plays a significant role in glucose metabolism and insulin sensitivity. In addition to its metabolic effects, adiponectin also has anti-inflammatory, anti-oxidative, and vasoprotective properties, making it a potential therapeutic target for diabetic complications.
Diabetes mellitus, a chronic metabolic disorder characterized by hyperglycemia, presents a formidable global health challenge with its associated complications. Adiponectin, an adipocyte-derived hormone, has emerged as a significant player in glucose metabolism and insulin sensitivity. Beyond its metabolic effects, adiponectin exerts anti-inflammatory, anti-oxidative, and vasoprotective properties, making it an appealing therapeutic target for mitigating diabetic complications. The molecular mechanisms by which adiponectin impacts critical pathways implicated in diabetic nephropathy, retinopathy, neuropathy, and cardiovascular problems are thoroughly examined in this study. In addition, we explore possible treatment options for increasing adiponectin levels or improving its downstream signaling. The multifaceted protective roles of adiponectin in diabetic complications suggest its potential as a novel therapeutic avenue. However, further translational studies and clinical trials are warranted to fully harness the therapeutic potential of adiponectin in the management of diabetic complications. This review highlights adiponectin as a promising target for the treatment of diverse diabetic complications and encourages continued research in this pivotal area of diabetes therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据